688317 之江生物
已收盘 07-10 15:00:02
资讯
新帖
简况
每周股票复盘：之江生物（688317）埃博拉试剂获WHO应急使用授权
证券之星 · 07-12 02:49
每周股票复盘：之江生物（688317）埃博拉试剂获WHO应急使用授权
之江生物(688317.SH)：埃博拉病毒核酸检测试剂盒(荧光PCR法)列入WHO应急使用清单
智通财经网 · 07-06
之江生物(688317.SH)：埃博拉病毒核酸检测试剂盒(荧光PCR法)列入WHO应急使用清单
之江生物：埃博拉病毒核酸检测试剂盒被列入WHO应急使用清单
格隆汇 · 07-06
之江生物：埃博拉病毒核酸检测试剂盒被列入WHO应急使用清单
每周股票复盘：之江生物（688317）回购422.8万股并注销231.4万股
证券之星 · 07-05
每周股票复盘：之江生物（688317）回购422.8万股并注销231.4万股
之江生物（688317）披露回购股份注销暨股份变动公告，7月1日股价上涨4.74%
证券之星 · 07-01
之江生物（688317）披露回购股份注销暨股份变动公告，7月1日股价上涨4.74%
之江生物三连亏：集采“砍价”击穿价盘，25亿资金沉睡难救业绩颓势
新浪证券 · 06-26
之江生物三连亏：集采“砍价”击穿价盘，25亿资金沉睡难救业绩颓势
股市必读：之江生物（688317）6月23日董秘有最新回复
证券之星 · 06-24
股市必读：之江生物（688317）6月23日董秘有最新回复
之江生物：公司正在积极开展近期非洲地区埃博拉病毒检测试剂需求业务
证券之星 · 06-23
之江生物：公司正在积极开展近期非洲地区埃博拉病毒检测试剂需求业务
每周股票复盘：之江生物（688317）回购股份达总股本2.02%
证券之星 · 06-20
每周股票复盘：之江生物（688317）回购股份达总股本2.02%
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份比例达到总股本2%暨回购进展公告，6月18日股价上涨0.18%
证券之星 · 06-18
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份比例达到总股本2%暨回购进展公告，6月18日股价上涨0.18%
之江生物：红铠甲和蓝铠甲移动检测车属于移动P2+实验室
证券之星 · 06-04
之江生物：红铠甲和蓝铠甲移动检测车属于移动P2+实验室
之江生物：持续深耕传染病及肿瘤筛查、伴随诊断等核心领域
证券之星 · 06-04
之江生物：持续深耕传染病及肿瘤筛查、伴随诊断等核心领域
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌5.34%
证券之星 · 06-02
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌5.34%
股市必读：之江生物（688317）5月29日董秘有最新回复
证券之星 · 06-01
股市必读：之江生物（688317）5月29日董秘有最新回复
每周股票复盘：之江生物（688317）获多项海外产品认证
证券之星 · 05-24
每周股票复盘：之江生物（688317）获多项海外产品认证
之江生物（688317）披露公司产品获得相关认证的公告，5月20日股价上涨6.8%
证券之星 · 05-20
之江生物（688317）披露公司产品获得相关认证的公告，5月20日股价上涨6.8%
之江生物(688317.SH)：3项产品于近期获得相关认证
智通财经 · 05-19
之江生物(688317.SH)：3项产品于近期获得相关认证
之江生物（688317）披露2025年年度股东会决议公告，5月15日股价下跌2.45%
证券之星 · 05-15
之江生物（688317）披露2025年年度股东会决议公告，5月15日股价下跌2.45%
每周股票复盘：之江生物（688317）将召开2025年年度股东会
证券之星 · 05-10
每周股票复盘：之江生物（688317）将召开2025年年度股东会
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份的进展公告，5月7日股价上涨2.6%
证券之星 · 05-07
之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份的进展公告，5月7日股价上涨2.6%
加载更多
公司概况
公司名称：
上海之江生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-01-18
主营业务：
上海之江生物科技股份有限公司的主营业务是分子诊断试剂和仪器设备的研发、生产和销售。公司的主要产品是分子诊断试剂、仪器设备。公司项目在上海市重点产品质量攻关成果中获得二等奖。
发行价格：
43.22
{"stockData":{"symbol":"688317","market":"SH","secType":"STK","nameCN":"之江生物","latestPrice":15.67,"timestamp":1783666802000,"preClose":15.22,"halted":0,"volume":2362522,"delay":0,"changeRate":0.0296,"floatShares":190000000,"shares":190000000,"eps":-0.2307,"marketStatus":"已收盘","change":0.45,"latestTime":"07-10 15:00:02","open":15.2,"high":15.96,"low":15.04,"amount":37070500,"amplitude":0.0604,"askPrice":15.67,"askSize":67,"bidPrice":15.66,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.2307,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.22,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":16.74,"lowLimit":13.7,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":189843712,"isCdr":false,"pbRate":0.9,"roa":"--","roe":"--","epsLYR":-0.19,"committee":-0.194805,"marketValue":2975000000,"turnoverRate":0.0124,"status":0,"afterMarket":{"amount":3134,"volume":200,"close":15.67,"buyVolume":1800,"sellVolume":0,"time":1783668837746,"indexStatus":"已收盘 07-10 15:30:00","preClose":15.22},"floatMarketCap":2975000000},"requestUrl":"/m/hq/s/688317","defaultTab":"news","newsList":[{"id":"2650154232","title":"每周股票复盘：之江生物（688317）埃博拉试剂获WHO应急使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650154232?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:49","pubTimestamp":1783795748,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，之江生物报收于15.67元，较上周的15.97元下跌1.88%。本周，之江生物7月7日盘中最高价报16.58元。本周关注点公司公告汇总：之江生物埃博拉病毒核酸检测试剂盒被列入WHO应急使用清单。公司公告汇总之江生物：关于自愿披露公司产品列入WHO应急使用清单的公告上海之江生物科技股份有限公司的埃博拉病毒核酸检测试剂盒于2026年7月2日被列入世界卫生组织应急使用清单，产品申请号为EUL 14468-139-00，货号QR-0220-02，采购期限为1年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649628076","title":"之江生物(688317.SH)：埃博拉病毒核酸检测试剂盒(荧光PCR法)列入WHO应急使用清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2649628076","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649628076?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:11","pubTimestamp":1783332701,"startTime":"0","endTime":"0","summary":"之江生物(688317.SH)发布公告，公司产品埃博拉病毒核酸检测试剂盒(荧光PCR法)于近日收到世界卫生组织(“WHO”)通知，于2026年7月2日被列入WHO应急使用清单(英文全称“WHO \nEmergency Use List”，简称“EUL”)。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/22.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/22.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688317","BK0239","PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649628255","title":"之江生物：埃博拉病毒核酸检测试剂盒被列入WHO应急使用清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2649628255","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649628255?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:59","pubTimestamp":1783331969,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649069246","title":"每周股票复盘：之江生物（688317）回购422.8万股并注销231.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649069246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649069246?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:18","pubTimestamp":1783196291,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，之江生物报收于15.97元，较上周的15.09元上涨5.83%。本周，之江生物7月2日盘中最高价报16.19元。本周关注点来自公司公告汇总：之江生物注销2,314,287股回购股份，占注销前总股本1.20%。来自公司公告汇总：截至2026年6月30日，之江生物累计回购4,228,495股，支付金额83,698,692.59元。本次注销完成后，公司总股本将由192,157,999股减少至188,843,712股，注册资本相应减少。回购股份原计划用于员工持股或股权激励，现变更为注销并减少注册资本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648514941","title":"之江生物（688317）披露回购股份注销暨股份变动公告，7月1日股价上涨4.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648514941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648514941?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:12","pubTimestamp":1782900755,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，之江生物报收于15.92元，较前一交易日上涨4.74%，最新总市值为30.22亿元。之江生物于近日披露《关于实施回购股份注销暨股份变动的公告》。公告显示，公司拟注销回购专用证券账户中的2,314,287股股份，占注销前总股本的1.20%。本次注销完成后，公司总股本将由192,157,999股减少至189,843,712股，注册资本相应减少。回购股份原计划用于员工持股或股权激励，现变更为注销并减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100035626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646332528","title":"之江生物三连亏：集采“砍价”击穿价盘，25亿资金沉睡难救业绩颓势","url":"https://stock-news.laohu8.com/highlight/detail?id=2646332528","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646332528?lang=zh_cn&edition=full","pubTime":"2026-06-26 15:32","pubTimestamp":1782459120,"startTime":"0","endTime":"0","summary":"连续三年营收下滑、净利润为负——之江生物正陷入一场集采降价与战略失焦的双重困局。尽管2025年亏损额从1.27亿元收窄至3429.76万元，但这份年报背后暴露出的问题远非“减亏”二字所能掩盖：核心产品销量增、收入减，价盘系统性崩塌；账面货币资金超25亿元，募投项目却进展迟缓；进入2026年一季度，营收同比暴跌近九成，颓势未见底。 之江生物的业务困局，最直观地体现在“量增价崩”的背离上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-06-26/doc-inietnfu5196079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645859624","title":"股市必读：之江生物（688317）6月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645859624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645859624?lang=zh_cn&edition=full","pubTime":"2026-06-24 04:00","pubTimestamp":1782244843,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，之江生物报收于16.59元，上涨1.41%，换手率1.59%，成交量3.06万手，成交额5104.74万元。董秘最新回复投资者： 请问贵公司近期是否有与非洲签订埃博拉病毒试剂的相关订单与业务产品董秘： 尊敬的投资者，您好！公司正在积极开展近期非洲地区埃博拉病毒检测试剂需求业务，相关经营情况请以公司披露的定期报告或相关公告为准。当日关注点交易信息汇总：6月23日主力资金净流出258.9万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400004317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645288925","title":"之江生物：公司正在积极开展近期非洲地区埃博拉病毒检测试剂需求业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2645288925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645288925?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:21","pubTimestamp":1782202897,"startTime":"0","endTime":"0","summary":"证券之星消息，之江生物(688317)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司近期是否有与非洲签订埃博拉病毒试剂的相关订单与业务产品之江生物回复：尊敬的投资者，您好！公司正在积极开展近期非洲地区埃博拉病毒检测试剂需求业务，相关经营情况请以公司披露的定期报告或相关公告为准。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300027184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065957","title":"每周股票复盘：之江生物（688317）回购股份达总股本2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065957?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:02","pubTimestamp":1781895737,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，之江生物报收于16.37元，较上周的17.12元下跌4.38%。本周，之江生物6月15日盘中最高价报17.25元。回购股份拟用于员工持股计划或股权激励，回购期限为2025年10月15日至2026年10月14日，预计回购金额为6,000万元至12,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084254","title":"之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份比例达到总股本2%暨回购进展公告，6月18日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644084254?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:46","pubTimestamp":1781793978,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，之江生物报收于16.37元，较前一交易日上涨0.18%，最新总市值为31.46亿元。近日，之江生物发布《关于2025年第三次以集中竞价交易方式回购公司股份比例达到总股本2%暨回购进展公告》。公告显示，公司自2025年10月15日起实施股份回购，截至2026年6月17日，累计回购股份3,879,832股，占公司总股本的2.02%，与上次披露数相比增加0.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640159083","title":"之江生物：红铠甲和蓝铠甲移动检测车属于移动P2+实验室","url":"https://stock-news.laohu8.com/highlight/detail?id=2640159083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640159083?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:27","pubTimestamp":1780568869,"startTime":"0","endTime":"0","summary":"证券之星消息，之江生物06月04日在投资者关系平台上答复投资者关心的问题。公司推出的“红铠甲”和“蓝铠甲”移动检测车属于移动P2+实验室，搭载自主研发的自动化核酸检测设备及智能管理系统，实现从样本采集到出具报告的全流程智慧化作业。该移动检测体系可应用于现场快速检测场景。公司将密切关注全球公共卫生动态，积极拓展海外市场布局，为全球公共卫生健康贡献之江力量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400032835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640159085","title":"之江生物：持续深耕传染病及肿瘤筛查、伴随诊断等核心领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2640159085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640159085?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:27","pubTimestamp":1780568868,"startTime":"0","endTime":"0","summary":"证券之星消息，之江生物06月04日在投资者关系平台上答复投资者关心的问题。关于您提到的埃博拉病毒相关订单，公司持续关注并积极承接相关业务需求。在此基础上，针对公司新的利润增长点及扭亏为盈的举措，公司依托自有研究院构建了坚实的中长期技术储备，持续深耕传染病及肿瘤筛查、伴随诊断等核心领域，大力发展分子诊断试剂及配套自动化设备，夯实主营业务基础，努力创造稳定的现金流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400032828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911340","title":"之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640911340?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:43","pubTimestamp":1780393393,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，之江生物报收于19.14元，较前一交易日下跌5.34%，最新总市值为36.78亿元。该股当日开盘20.12元，最高20.43元，最低18.92元，成交额达1.4亿元，换手率为3.76%。近日，之江生物发布《关于2025年第三次以集中竞价交易方式回购公司股份的进展公告》。2026年5月单月回购107,500股，支付资金2,109,645.00元。本次回购符合相关法规及公司回购方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200034565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640985598","title":"股市必读：之江生物（688317）5月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640985598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640985598?lang=zh_cn&edition=full","pubTime":"2026-06-01 03:08","pubTimestamp":1780254494,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，之江生物报收于22.2元，下跌1.46%，换手率4.45%，成交量8.55万手，成交额1.93亿元。董秘最新回复投资者： 请问贵司世卫组织和非洲埃博拉病毒入侵的国家订单接到了吗，试剂盒运出去多少啊。公司始终严格遵守各项监管规定，及时履行信息披露义务。相关经营情况请以公司披露的定期报告或相关公告为准。当日关注点来自交易信息汇总：5月29日主力资金净流出800.12万元，占总成交额4.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100001333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373458","title":"每周股票复盘：之江生物（688317）获多项海外产品认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373458","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373458?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:40","pubTimestamp":1779561621,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，之江生物报收于20.77元，较上周的19.12元上涨8.63%。本周，之江生物5月20日盘中最高价报22.66元。本周关注点公司公告汇总：全自动核酸提取纯化及实时荧光PCR分析系统获荷兰当局认证，拓展欧盟市场。公司公告汇总之江生物：关于自愿披露公司产品获得相关认证的公告上海之江生物科技股份有限公司及全资子公司近期获得3项产品认证。产品面临市场竞争及利润贡献不确定性风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636848742","title":"之江生物（688317）披露公司产品获得相关认证的公告，5月20日股价上涨6.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636848742","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636848742?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:56","pubTimestamp":1779270975,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，之江生物报收于21.66元，较前一交易日上涨6.8%，最新总市值为41.62亿元。该股当日开盘20.66元，最高22.66元，最低20.66元，成交额达2.61亿元，换手率为6.23%。之江生物于近日披露《关于自愿披露公司产品获得相关认证的公告》。公告同时提示，上述产品面临市场竞争及利润贡献不确定性风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636834967","title":"之江生物(688317.SH)：3项产品于近期获得相关认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2636834967","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636834967?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:29","pubTimestamp":1779182945,"startTime":"0","endTime":"0","summary":"智通财经APP讯，之江生物(688317.SH)发布公告，公司及全资子公司上海之江生物医药科技有限公司3项产品于近期获得相关认证，获认证产品为：“全自动核酸提取纯化及实时荧光PCR分析系统”、“实时荧光定量PCR分析仪”、“白血病JAK2基因V617F突变测定试剂盒(荧光 PCR法)”。上述产品获得认证后，可在欧盟/墨西哥和认可欧盟/墨西哥认证的国家进行销售，进一步提升了公司的国际化竞争力，对于公司扩充海外销售产品品类及国际业务拓展具有积极作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"之江生物(688317.SH)：3项产品于近期获得相关认证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635002997","title":"之江生物（688317）披露2025年年度股东会决议公告，5月15日股价下跌2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635002997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635002997?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:44","pubTimestamp":1778838254,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，之江生物报收于19.12元，较前一交易日下跌2.45%，最新总市值为36.74亿元。该股当日开盘19.68元，最高19.68元，最低19.09元，成交额达4590.32万元，换手率为1.24%。之江生物于近日披露《2025年年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500034423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634414533","title":"每周股票复盘：之江生物（688317）将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634414533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634414533?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:20","pubTimestamp":1778350820,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，之江生物报收于20.83元，较上周的19.5元上涨6.82%。本周关注点公司公告汇总：之江生物将于2026年5月14日召开2025年年度股东会，审议董事会工作报告、利润分配等议案。之江生物：关于召开2025年年度业绩说明会的公告上海之江生物科技股份有限公司将于2026年5月18日09:00-10:00通过上证路演中心网络互动方式召开2025年年度业绩说明会，介绍公司年度经营成果及财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126691","title":"之江生物（688317）披露2025年第三次以集中竞价交易方式回购公司股份的进展公告，5月7日股价上涨2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633126691?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:42","pubTimestamp":1778164937,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，之江生物报收于20.11元，较前一交易日上涨2.6%，最新总市值为38.64亿元。该股当日开盘19.6元，最高20.52元，最低19.56元，成交额达5749.27万元，换手率为1.49%。近日，之江生物发布《关于2025年第三次以集中竞价交易方式回购公司股份的进展公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783879148185,"stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":-0.0905},{"period":"3month","weight":-0.251},{"period":"6month","weight":-0.2605},{"period":"1year","weight":-0.1923},{"period":"ytd","weight":-0.2231}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0025},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海之江生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15499人(较上一季度增加13.72%)","perCapita":"12248股","listingDate":"2021-01-18","address":"上海市浦东新区张江高科技产业东区瑞庆路528号20幢乙号1层、21幢甲号1层","registeredCapital":"18984万元","survey":" 上海之江生物科技股份有限公司的主营业务是分子诊断试剂和仪器设备的研发、生产和销售。公司的主要产品是分子诊断试剂、仪器设备。公司项目在上海市重点产品质量攻关成果中获得二等奖。","listedPrice":43.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"之江生物(688317)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供之江生物(688317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"之江生物,688317,之江生物股票,之江生物股票老虎,之江生物股票老虎国际,之江生物行情,之江生物股票行情,之江生物股价,之江生物股市,之江生物股票价格,之江生物股票交易,之江生物股票购买,之江生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"之江生物(688317)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供之江生物(688317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}